retatrutide clinical trial phase retatrutide us Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a trial Lilly's 'triple G' agonist triumphs

GLP-1s are relatively new drugs, and there are a lot of unknowns about side effects, says Dr

Nalani Yim took over for the fourth quarter and shutout the Gauchos, stopping four shots to tie her season and career highs

Like any medication, there is a potential for side effects when taking semaglutide, oral semaglutide, or tirzepatide

Mitochondrial-mediated ROS cause oxidative damage to cellular structures, particularly mitochondrial DNA, somatic mutations, genome instability, inactivation of tumor suppressor genes, alterations in metabolic and signaling pathways with simultaneous activation of compensatory antioxidant mechanisms, all of which contribute to cell transformation and thus promote various types of cancer [42]

Swelling or Ballooning Swelling is often the first visible sign of damage or stress in a LiPo cell

Why is everyone talking about GLP-1s and not SGLT2 inhibitors in 2026